A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies

REFERENCES

1. 1.↵
   2. Gill BJ,
   3. Pisapia DJ,
   4. Malone HR, et al

   . MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma. Proc Natl Acad Sci U S A 2014;111:12550–55 doi:10.1073/pnas.1405839111 pmid:25114226

   Abstract/FREE Full Text
2. 2.↵
   2. Barajas RF,
   3. Phillips JJ,
   4. Parvataneni R, et al

   . Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR imaging. Neuro Oncol 2012;14:942–54 doi:10.1093/neuonc/nos128 pmid:22711606

   Abstract/FREE Full Text
3. 3.↵
   2. Sadeghi N,
   3. D'Haene N,
   4. Decaestecker C, et al

   . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82 doi:10.3174/ajnr.A0851 pmid:18079184

   Abstract/FREE Full Text
4. 4.↵
   2. Stadnik TW,
   3. Chaskis C,
   4. Michotte A, et al

   . Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001;22:969–76 pmid:11337344

   Abstract/FREE Full Text
5. 5.↵
   2. Wallner KE,
   3. Galicich JH,
   4. Krol G, et al

   . Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405–09 doi:10.1016/0360-3016(89)90941-3 pmid:2542195

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Liang BC,
   3. Thornton AF,
   4. Sandler HM, et al

   . Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 1991;75:559–63 doi:10.3171/jns.1991.75.4.0559 pmid:1653309

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Stupp R,
   3. Mason WP,
   4. van den Bent MJ, et al

   ; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96 doi:10.1056/NEJMoa043330 pmid:15758009

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Burger PC,
   3. Heinz ER,
   4. Shibata T, et al

   . Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:698–704 pmid:2833587

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Price SJ,
   3. Gillard JH

   . Imaging biomarkers of brain tumour margin and tumour invasion. Br J Radiol 2011;84(Spec No 2):S159–67 doi:10.1259/bjr/26838774 pmid:22433826

   Abstract/FREE Full Text
10. 10.↵
    2. LaViolette PS,
    3. Mickevicius NJ,
    4. Cochran EJ, et al

    . Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro Oncol 2014;16:1599–606 doi:10.1093/neuonc/nou142 pmid:25059209

    Abstract/FREE Full Text
11. 11.↵
    2. Sugahara T,
    3. Korogi Y,
    4. Kochi M, et al

    . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60 pmid:10030650

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Kono K,
    3. Inoue Y,
    4. Nakayama K, et al

    . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88 pmid:11415902

    Abstract/FREE Full Text
13. 13.↵
    2. Guo AC,
    3. Cummings TJ,
    4. Dash RC, et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83 doi:10.1148/radiol.2241010637 pmid:12091680

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Akbari H,
    3. Macyszyn L,
    4. Da X, et al

    . Imaging surrogates of infiltration obtained via multiparametric imaging pattern analysis predict subsequent location of recurrence of glioblastoma. Neurosurgery 2016;78:572–80 doi:10.1227/NEU.0000000000001202 pmid:26813856

    CrossRefPubMed
15. 15.↵
    2. Pope WB,
    3. Chen JH,
    4. Dong J, et al

    . Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology 2008;249:268–77 doi:10.1148/radiol.2491072000 pmid:18796682

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Tynninen O,
    3. Aronen HJ,
    4. Ruhala M, et al

    . MRI enhancement and microvascular density in gliomas: correlation with tumor cell proliferation. Invest Radiol 1999;34:427–34 doi:10.1097/00004424-199906000-00007 pmid:10353036

    CrossRefPubMed
17. 17.↵
    2. Watkins S,
    3. Robel S,
    4. Kimbrough IF, et al

    . Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 2014:5:4196 doi:10.1038/ncomms5196 pmid:24943270

    CrossRefPubMed
18. 18.↵
    2. Hu LS,
    3. Ning S,
    4. Eschbacher JM, et al

    . Multi-parametric MRI and texture analysis to visualize spatial histologic heterogeneity and tumor extent in glioblastoma. PLoS One 2015;10:e0141506 doi:10.1371/journal.pone.0141506 pmid:26599106

    CrossRefPubMed
19. 19.↵
    2. Jenkinson M,
    3. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56 doi:10.1016/S1361-8415(01)00036-6 pmid:11516708

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Jenkinson M,
    3. Bannister P

    . Improved methods for the registration and motion correction of brain images. Neuroimage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Shapira D,
    3. Avidan S,
    4. Hel-Or Y

    . Multiple histogram matching. In: 2013 IEEE International Conference on Image Processing, Melbourne, Australia. September 15–18, 2013:2269–73 doi:10.1109/ICIP.2013.6738468
22. 22.↵
    2. Lyng H,
    3. Haraldseth O,
    4. Rofstad EK

    . Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828–36 pmid:10861877

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Chenevert TL,
    3. Stegman LD,
    4. Taylor JM, et al

    . Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029–36 doi:10.1093/jnci/92.24.2029 pmid:11121466

    Abstract/FREE Full Text
24. 24.↵
    2. Hayashida Y,
    3. Hirai T,
    4. Morishita S, et al

    . Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006;27:1419–25 pmid:16908550

    Abstract/FREE Full Text
25. 25.↵
    2. Ellingson BM,
    3. Malkin MG,
    4. Rand SD, et al

    . Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010;31:538–48 doi:10.1002/jmri.22068 pmid:20187195

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Cuddapah VA,
    3. Robel S,
    4. Watkins S, et al

    . A neurocentric perspective on glioma invasion. Nat Rev Neurosci 2014;15:455–65 doi:10.1038/nrn3765 pmid:24946761

    CrossRefPubMed
27. 27.↵
    2. Scherer HJ

    . Cerebral astrocytomas and their derivatives. Cancer Res 1940;40:159–98 doi:10.1158/ajc.1940.159

    CrossRef
28. 28.↵
    2. Trantakis C,
    3. Tittgemeyer M,
    4. Schneider JP, et al

    . Investigation of time-dependency of intracranial brain shift and its relation to the extent of tumor removal using intra-operative MRI. Neurol Res 2003;25:9–12 doi:10.1179/016164103101200923 pmid:12564118

    CrossRefPubMed